Composition for regulating production of interfering ribonucleic acid
AssigneeWyvern Pharmaceuticals Inc.
InventorBradley G. Thompson
Life of this patent
Estimating the term…
Loading patent…
AssigneeWyvern Pharmaceuticals Inc.
InventorBradley G. Thompson
Estimating the term…
Some embodiments of the present disclosure relate to one or more compositions that upregulate the production of one or more sequences of micro-interfering ribonucleic acid (miRNA). The miRNA may be complimentary to a sequence of target messenger RNA (mRNA) that encodes for a target biomolecule and the miRNA can cause the target mRNA to be degraded or inactivated, decreasing the bioavailability of the target biomolecule within a subject that is administered the one or more compositions. In some embodiments of the present disclosure, the target biomolecule is a complement or a factor. In some embodiments of the present disclosure, the target biomolecule is a complement such as complement C1q, complement C1r, complement C1s, complement C3 or complement C5. In some embodiments of the present disclosure, the target biomolecule is a factor such as Factor B, Factor D or Factor 10.
A composition that comprises a recombinant plasmid (RP) comprising a sequence of nucleotides that is SEQ ID NO. 3.
A composition that comprises a recombinant plasmid (RP) comprising a sequence of nucleotides that is SEQ ID NO 11.
Dependencies are inferred from the claim text.